Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
All News
Headline News
Benzinga
Chartmill
The Motley Fool
InvestorPlace
Investor's Business Daily
MarketBeat
StockStory
Talk Markets
Press Releases
24-7 Press Release
AB Newswire
ACCESSWIRE
ACN Newswire
Authority Press Wire
Binary News Network
Brandpoint
Business Wire
CannabisNewsWire
CryptoCurrencyWire
Equities.com
eTrendy Stock
EZ Newswire
FinancialNewsMedia
Get News
getfeatured.news
GlobePRwire
Globe NewsWire
InvestorBrandNetwork
JCN Newswire
Law Firm Newswire
MediaOutReach
MerxWire
News Direct
Newsfile
NewsUSA
Newswire.com
Newsworthy.ai
Press Advantage
Press Release Distribution Service
PressConnect.ai
PressReach
PRLeap
PRLog
Prodigy
ReleaseWire
Small Business Trendsetters
Send2Press
StatePoint
Syndication Cloud
TheNewswire
Zexprwire
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
99
100
Next >
Adagene Presents Two Posters with New Insights on Increased Therapeutic Index for Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) and Data Reinforcing Clinical Safety and Efficacy for ADG126 as Monotherapy and in Combination with Anti-PD-1 Therapy at
November 07, 2024
From
Adagene Inc.
Via
GlobeNewswire
Tickers
ADAG
MiNK’s iNKT Cell Therapy Shows Potential for Optimal Multi-Combination for Resistant Solid Cancers at SITC 2024
November 07, 2024
From
MiNK Therapeutics
Via
GlobeNewswire
Tickers
INKT
Allogene Therapeutics Announces Positive Phase 1 Data Demonstrating the Potential of ALLO-316 in Heavily Pretreated Patients with Advanced Renal Cell Carcinoma at SITC and IKCS
November 07, 2024
From
Allogene Therapeutics, Inc.
Via
GlobeNewswire
Tickers
ALLO
Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting
November 07, 2024
From
Bolt Biotherapeutics, Inc.
Via
GlobeNewswire
Tickers
BOLT
Qualifacts and Cook County Public Health and Human Services Partner to Enhance the County’s Behavioral Health Services
November 07, 2024
From
Qualifacts
Via
GlobeNewswire
It’s Peanut Butter Lovers Month! Enter to Win a Year of new Gardners Candies Peanut Butter Meltaway Grahams
November 07, 2024
From
Gardners Candies
Via
GlobeNewswire
Almost 90% of Metro Areas Posted Home Price Increases in Third Quarter of 2024
November 07, 2024
From
National Association of Realtors®
Via
GlobeNewswire
Boris Herrmann aboard the Malizia-Seaexplorer under Monaco flag for the Vendée Globe, It’s the ultimate challenge
November 07, 2024
From
Yacht Club de Monaco
Via
GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ROIC, SMAR, ALTM on Behalf of Shareholders
November 07, 2024
From
Halper Sadeh LLC
Via
GlobeNewswire
Tickers
ALTM
ROIC
SMAR
INVESTOR REMINDER: Berger Montague Notifies Elanco Animal Health (NYSE: ELAN) Investors of a Class Action Lawsuit and Deadline
November 07, 2024
From
Berger Montague
Via
GlobeNewswire
Tickers
ELAN
Onex Fourth-Quarter Dividend Declared
November 07, 2024
From
ONEX Corporation
Via
GlobeNewswire
Tickers
TSX:ONEX
Aduro Clean Technologies Announces Pricing of US$4 Million Uplisting to Nasdaq
November 07, 2024
From
Aduro Clean Technologies Inc.
Via
GlobeNewswire
Tickers
ACTHF
CSE:ACT
York Water Company Reports 3rd Quarter and Nine Months Earnings
November 07, 2024
From
The York Water Company
Via
GlobeNewswire
Tickers
YORW
Jianzhi Education Technology Announces Major Initiative in Natural Language Processing
November 07, 2024
From
Jianzhi Education Technology Group Company Limited
Via
GlobeNewswire
Tickers
JZ
Top Kingwin Ltd's Subsidiary, Guji Technology, Achieves RMB 2Million in Revenue for October 2024
November 07, 2024
From
Top Kingwin Ltd
Via
GlobeNewswire
Tickers
WAI
Mullen Subsidiary, Bollinger Motors, Announces Its Approval by New York State for up to $100,000 Cash Voucher Incentive NYTVIP Program on the All-Electric B4 Truck
November 07, 2024
From
Mullen Automotive, Inc.
Via
GlobeNewswire
Tickers
MULN
Xilio Therapeutics Announces Initial Clinical Trial Data from Phase 1C Dose Escalation for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Advanced Solid Tumors
November 07, 2024
From
Xilio Therapeutics, Inc.
Via
GlobeNewswire
Tickers
XLO
Iterable Launches AI Academy to Meet Growing Demand for AI Skills Among Marketers
November 07, 2024
From
Iterable
Via
GlobeNewswire
Tejon Ranch Co. Announces Third Quarter 2024 Financial Results
November 07, 2024
From
Tejon Ranch Co
Via
GlobeNewswire
Tickers
TRC
MarketWise Reports Net Income of $22.7 Million and Net Revenue of $97.2 Million for Third Quarter 2024
November 07, 2024
From
MarketWise LLC
Via
GlobeNewswire
Tickers
MKTW
White House Representative Stephen Viña Warns of Rising China Cyber Threat at Sold Out NMFTA Cybersecurity Conference
November 07, 2024
From
National Motor Freight Traffic Association
Via
GlobeNewswire
International Centre for Dispute Resolution® Launches India Committee, Bolstering Dispute Resolution Frameworks in India
November 07, 2024
From
American Arbitration Association
Via
GlobeNewswire
The Accumulus Platform Powers Sanofi’s Submissions to Multiple Regulators Around the World
November 07, 2024
From
Accumulus Synergy
Via
GlobeNewswire
Circana Reveals U.S. Consumers Experience 6 Billion Special Occasions Annually, Offering Major Opportunities to Cater to Evolving Consumer Needs
November 07, 2024
From
Circana
Via
GlobeNewswire
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2024 Financial Results
November 07, 2024
From
Xilio Therapeutics, Inc.
Via
GlobeNewswire
Tickers
XLO
Werewolf Therapeutics Presents Preclinical and Clinical Data at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
November 07, 2024
From
Werewolf Therapeutics, Inc.
Via
GlobeNewswire
Tickers
HOWL
RAVE Restaurant Group, Inc. Reports First Quarter 2025 Results
November 07, 2024
From
Rave Restaurant Group, Inc.
Via
GlobeNewswire
Tickers
RAVE
Nutanix Expands Partnership with AWS
November 07, 2024
From
Nutanix, Inc.
Via
GlobeNewswire
Tickers
NTNX
Saga Communications, Inc. Reports 3rd Quarter 2024 Results
November 07, 2024
From
Saga Communications, Inc.
Via
GlobeNewswire
Tickers
SGA
Werewolf Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
November 07, 2024
From
Werewolf Therapeutics, Inc.
Via
GlobeNewswire
Tickers
HOWL
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.